top of page

Parow Entheobiosciences

Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes

Poster presentation abstracts at the 60th Annual Meeting of the American College of Neuropsychopharmacology, December 5-8, 2021

Scientists Create Cell-Based Psychedelic Toad Venom, a Potential 5-MeO-DMT “Bio-Factory”

Buried Treasure: How Does Psilocybin Reduce Compulsivity?

Publications

In the news

A long trip into the universe: Psychedelics and space travel

Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation

Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications

Poster presentations

Chromatography and the magic of mushrooms

Incilius alvarius cell-based synthesis of 5-MeO-DMT

Psychedelics use and placebo response.png

Psychedelic use and placebo response

ISBP HTR.png

Pharmacological Characterization of the Head Twitch Response

ANCP Poster.png

Psychedelic mushrooms in the USA

ISBP marble burying.png

Preclinical Studies on the Anti-Obsessional Properties of Psilocybin

Correlation between subjective experiences with 10 psychedelic mushrooms and tryptamine content

Psychedlic experience and Obsessice Compulsive.png

Subjective Psychedelic Experience and Obsessive-Compulsive Symptom Severity

Differences Between Synthetic Psilocybin and Psychedelic Mushroom Extract

Preclinical Studies on the Anti-Obsessional Properties of Psilocybin II

bottom of page